OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renal Autoregulation in Health and Disease
Mattias Carlström, Christopher S. Wilcox, William J. Arendshorst
Physiological Reviews (2015) Vol. 95, Iss. 2, pp. 405-511
Open Access | Times Cited: 414

Showing 1-25 of 414 citing articles:

Heart failure and kidney dysfunction: epidemiology, mechanisms and management
Joerg C. Schefold, Gerasimos Filippatos, Gerd Hasenfuß, et al.
Nature Reviews Nephrology (2016) Vol. 12, Iss. 10, pp. 610-623
Closed Access | Times Cited: 545

Obesity, kidney dysfunction and hypertension: mechanistic links
John E. Hall, Jussara M. do Carmo, Alexandre A. da Silva, et al.
Nature Reviews Nephrology (2019) Vol. 15, Iss. 6, pp. 367-385
Open Access | Times Cited: 495

Mitochondrial dysfunction in diabetic kidney disease
Josephine M. Forbes, David R. Thorburn
Nature Reviews Nephrology (2018) Vol. 14, Iss. 5, pp. 291-312
Closed Access | Times Cited: 456

Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology
Ele Ferrannini
Cell Metabolism (2017) Vol. 26, Iss. 1, pp. 27-38
Open Access | Times Cited: 285

Diuretic Therapy for Patients With Heart Failure
G. Michael Felker, David H. Ellison, Wilfried Müllens, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 10, pp. 1178-1195
Open Access | Times Cited: 281

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 257

Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis
Mattias Carlström, Susanna C. Larsson
Nutrition Reviews (2018) Vol. 76, Iss. 6, pp. 395-417
Open Access | Times Cited: 195

Nitric oxide signalling in kidney regulation and cardiometabolic health
Mattias Carlström
Nature Reviews Nephrology (2021) Vol. 17, Iss. 9, pp. 575-590
Open Access | Times Cited: 185

Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension
Shan Jiang, Yongjie Shui, Yu Cui, et al.
Redox Biology (2021) Vol. 46, pp. 102115-102115
Open Access | Times Cited: 149

Vascular mechanotransduction
Michael J. Davis, Scott Earley, Yi‐Shuan Li, et al.
Physiological Reviews (2023) Vol. 103, Iss. 2, pp. 1247-1421
Closed Access | Times Cited: 114

Oxidative stress and the role of redox signalling in chronic kidney disease
Seiji Kishi, Hajime Nagasu, Kengo Kidokoro, et al.
Nature Reviews Nephrology (2023) Vol. 20, Iss. 2, pp. 101-119
Closed Access | Times Cited: 98

Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?
Stéphane Laurent, Claudia Agabiti-Rosei, Rosa María Bruno, et al.
Hypertension (2022) Vol. 79, Iss. 3, pp. 479-490
Open Access | Times Cited: 73

Renal Handling of Ketones in Response to Sodium–Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes
Ele Ferrannini, Simona Baldi, Silvia Frascerra, et al.
Diabetes Care (2017) Vol. 40, Iss. 6, pp. 771-776
Open Access | Times Cited: 151

Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension
John E. Hall
Circulation (2016) Vol. 133, Iss. 9, pp. 894-906
Open Access | Times Cited: 141

Nephron Protection in Diabetic Kidney Disease
Hans‐Joachim Anders, John M. Davis, Klaus Thurau
New England Journal of Medicine (2016) Vol. 375, Iss. 21, pp. 2096-2098
Closed Access | Times Cited: 115

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, et al.
Diabetologia (2016) Vol. 59, Iss. 7, pp. 1412-1421
Open Access | Times Cited: 111

Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease
Karen A. Griffin
Hypertension (2017) Vol. 70, Iss. 4, pp. 687-694
Open Access | Times Cited: 103

A bidirectional Mendelian randomization study supports causal effects of kidney function on blood pressure
Zhi Yu, Josef Coresh, Guanghao Qi, et al.
Kidney International (2020) Vol. 98, Iss. 3, pp. 708-716
Open Access | Times Cited: 102

Personalized hemodynamic management
Bernd Saugel, Jean‐Louis Vincent, Julia Y. Wagner
Current Opinion in Critical Care (2017) Vol. 23, Iss. 4, pp. 334-341
Closed Access | Times Cited: 99

Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites
Luís Téllez, Luis Ibáñez, Candelas Pérez del Villar, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 6, pp. 1404-1414
Closed Access | Times Cited: 86

Renal Denervation Update From the International Sympathetic Nervous System Summit
Márcio Galindo Kiuchi, Murray Esler, Gregory D. Fink, et al.
Journal of the American College of Cardiology (2019) Vol. 73, Iss. 23, pp. 3006-3017
Open Access | Times Cited: 83

Renoprotective mechanisms of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease
Sreenithya Ravindran, Shankar Munusamy
Journal of Cellular Physiology (2021) Vol. 237, Iss. 2, pp. 1182-1205
Closed Access | Times Cited: 62

Role of perioperative hypotension in postoperative acute kidney injury: a narrative review
Yugeesh R. Lankadeva, Clive N. May, Rinaldo Bellomo, et al.
British Journal of Anaesthesia (2022) Vol. 128, Iss. 6, pp. 931-948
Open Access | Times Cited: 47

Page 1 - Next Page

Scroll to top